Leone Roberti Maggiore U, Ferrero S. Methodological concerns on ‘Assessment of ovarian reserve after cystectomy versus “one-step” laser vaporization in the treatment of ovarian endometrioma: a small randomized clinical trial’. Hum Reprod. 2019 Oct 2;34(10):2086-2087. https://academic.oup.com/humrep/article-abstract/34/10/2086/5580758?redirectedFrom=fulltext
Atomic force microscopy: a promising aid in diagnosis of uterine smooth muscle neoplasms
Peñuela LA, Fulcheri E, Vellone VG, Fiocca R, Vigliercio GM, Raiteri R, Ferrero S. Atomic force microscopy: a promising aid in diagnosis of uterine smooth muscle neoplasms. Am J Obstet Gynecol 2019;221:362-364. https://www.ajog.org/article/S0002-9378(19)30671-4/fulltext
Circulating Endometrial Cells: A New Source of Information on Endometriosis Dynamics
Pospisilova E, Kiss I, Souckova H, Tomes P, Spicka J, Matkowski R, Jedryka M, Ferrero S, Bobek V Kolostova K. Circulating Endometrial Cells: A New Source of Information on Endometriosis Dynamics. J Clin Med 2019;8(11). https://www.mdpi.com/2077-0383/8/11/1938
Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going?
Barra F, Laganà AS, Casarin J, Ghezzi F, Ferro Desideri L, Scala C, Ferrero S. Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going? Int J Fertil Steril 2019;13:89-92. http://ijfs.ir/journal/article/abstract/5736
Impact of Endometriomas and Deep Infiltrating Endometriosis on Pregnancy Outcomes and on First and Second Trimester Markers of Impaired Placentation
Scala C, Leone Roberti Maggiore U, Barra F, Tantari M, Ferrero S. Impact of Endometriomas and Deep Infiltrating Endometriosis on Pregnancy Outcomes and on First and Second Trimester Markers of Impaired Placentation. Medicina (Kaunas);55(9). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780829/
Preoperative Hormonal Treatment Before Laparoscopic Approach for Uterine Fibroids: Do We Need It?
Barra F, Evangelisti G, Ferrero S. Preoperative Hormonal Treatment Before Laparoscopic Approach for Uterine Fibroids: Do We Need It? J Invest Surg. 2019 Aug 28:1-3. https://www.tandfonline.com/doi/full/10.1080/08941939.2019.1655118
Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs
Moioli M, Barra F, Maramai M, Valenzano Menada M, Vellone VG, Costantini S, Ferrero S. Mucinous ovarian cancer: current therapeutic targets, preclinical progress, and experimental drugs. Expert Opin Investig Drugs 2019;28:1025-1029. https://www.tandfonline.com/doi/abs/10.1080/13543784.2019.1693999?journalCode=ieid20
Application of failure mode and effect analysis in total laparoscopic hysterectomy in benign conditions
Lijoi D, Farina M, Puppo A, Novelli A, Ferrero S. Application of failure mode and effect analysis in total laparoscopic hysterectomy in benign conditions. Minerva Ginecol. 2019 Aug;71(4):272-280. https://www.minervamedica.it/it/riviste/minerva-ginecologica/articolo.php?cod=R09Y2019N04A0272
Relugolix for the treatment of uterine fibroids
Barra F, Seca M, Della Corte L, Giampaolino P, Ferrero S. Relugolix for the treatment of uterine fibroids. Drugs Today (Barc) 2019;55:503-512. https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=3020179
Cervical intraepithelial neoplasia in women who had vaccination against HPV
Bogani G, Serati M, Maggiore ULR, Ditto A, Gardella B, Ferrero S, Spinillo A, Ghezzi F, Raspagliesi F. Cervical intraepithelial neoplasia in women who had vaccination against HPV. Int J Gynaecol Obstet 2019;147:233-237. https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1002/ijgo.12934